Journal of Vaccines & Vaccination

16^th Euro Global Summit and Expo on Vaccines & Vaccination

June 19-21, 2017 Paris, France

Scientific Tracks Abstracts

• Addressing challenges and solution for using T cell based assays for immune monitoring

  Magdalena Tary-Lehmann

  PDF HTML

• Stability modeling to predict vaccine shelf-life and evaluate impact of temperature excursions from the cold chain

  Didier Clenet

  PDF HTML

• Multi-epitope fusion antigen (MEFA), novel technology for structural vaccinology

  Weiping Zhang, Rahul Nandre and Qiangde Duan

  PDF HTML

• Singapore Immunology Networks clinical immunomonitoring platform for the assessment of immune responses in cohort studies and clinical trials

  Brian Abel

  PDF HTML

• Mucosal vaccination with accessory antigens provides surprisingly robust protection against early SIV replication: Underappreciated role of location and immunodominance in vaccination against chronic infection

  Peter Johannes Holst

  PDF HTML

• Vaccination coverage cluster surveys in Middle Dreib-Akkar, Lebanon: Comparison of vaccination coverage in children aged 12-59 months pre- and post-vaccination campaign

  Randa Hamadeh

  PDF HTML

• Responding to the threat of emergent infectious diseases

  Klaus Schwamborn

  PDF HTML

• Polio outbreak stopped in the Middle East, efforts are still needed

  Randa Hamadeh, Magdi Sharaf

  PDF HTML

• Modified MHCII associated invariant chain induces increased antibody responses against Plasmodium falciparum antigens after adenoviral vaccination

  Cyrielle Fougeroux and Peter J Holst

  PDF HTML

• Oil-based adjuvants and intradermal vaccine delivery: Th1 vs. Th2 response

  Zrinka Oreskovic and Martin Faldyna

  PDF HTML

• Bovine herpesvirus type 4-BAC as an attractive viral vector for vaccination and gene therapy

  Touraj Aligholipour Farzani, Seval Bilge Dagalp and Aykut Ozkul

  PDF HTML

• Study and evaluation of the pathogenicity of Moroccan strains of sheep pox

  Saida Hajjou, Khadija Khataby, Chafiqa Loutfi, Malika Fakiri

  PDF HTML

• Exploiting defects of type I interferon response in tumor cells for oncolytic immunotherapy with attenuated measles virus

  Jean-Francois Fonteneau

  PDF HTML

• Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors

  Karola Rittner

  PDF HTML

• Biogenic selenium nanoparticles can shift the immune response of breast cancer bearing mice toward Th1 pattern

  Mohammad Hossein Yazdi

  PDF HTML

• Recombinant lapidated subunit vaccines induce robust immunity against all four serotypes of dengue virus

  Hsin-Wei Chen

  PDF HTML

• Therapeutic vaccination in chronic infectious diseases: The place of vectored vaccines

  Genevieve Inchauspe

  PDF HTML

• A toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population

  Chih-Hsiang Leng

  PDF HTML

• Development of innovative vaccines by the combination of novel technologies

  Fumihiko Takeshita

  PDF HTML

• Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and ameliorates vaccine efficacy

  Ming-Hsi Huang

  PDF HTML

• Kinetics of myeloid derived suppressor cells (MDSC) and their effect on vaccine-specific responses during the first year of life

  Ana Gervassi, Elvis Kidzeru, Leesa Kim, Soren Gantt, Heather Jaspan and Helen Horton

  PDF HTML